Vitamin D status at birth and acute respiratory infection hospitalisation during infancy

Rajneeta Saraf1, Berit P Jensen2, Carlos A Camargo3

  • 1Department of Paediatrics, Child and Youth Health, The University of Auckland, Auckland, New Zealand.

Insights

Vitamin D deficiency at birth increases infant hospitalizations for acute respiratory infections (ARIs). Supplementation may reduce ARI hospitalizations in infants, especially where deficiency is common.

Area of Science:

  • Pediatrics
  • Public Health
  • Nutritional Science

Background:

  • Acute respiratory infections (ARIs) in early childhood are a significant global health issue.
  • Vitamin D deficiency is common in pregnant women and infants.
  • Existing evidence suggests vitamin D supplementation can prevent ARIs.

Purpose of the Study:

  • To investigate the association between vitamin D deficiency at birth and hospitalization for ARIs during infancy.

Main Methods:

  • A nested case-control study involving infants aged 0-12 months.
  • Cases were infants with at least one ARI hospitalization; four controls were matched per case.
  • Newborn 25-hydroxyvitamin D [25(OH)D] levels were measured from dried blood spots; ARI hospitalizations were identified from healthcare records.

Main Results:

  • Infants hospitalized for ARIs had lower median 25(OH)D levels at birth compared to controls (46 nmol/L vs. 61 nmol/L).
  • Lower 25(OH)D levels were associated with multiple hospitalizations and longer hospital stays.
  • Vitamin D deficiency at birth (25(OH)D < 50 nmol/L) was linked to a 2.20-fold increased odds of ARI hospitalization, even after adjusting for various covariates.

Conclusions:

  • Vitamin D deficiency in newborns is associated with a higher risk of ARI hospitalizations in infants.
  • These findings are particularly relevant for countries like New Zealand, where routine vitamin D supplementation is not standard practice, yet ARI hospitalizations in young children are frequent.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
565
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
6.9K
Vaccinations01:51

Vaccinations

Overview
49.0K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.0K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
276
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
82